BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7553959)

  • 21. Treatment of 23 patients with advanced gastric cancer by intravenously transfer of autologous tumor-infiltrating lymphocytes combined with rIL-2.
    Xu X; Xu L; Ding S; Wu M; Tang Z; Fu W; Ni Q
    Chin Med Sci J; 1995 Sep; 10(3):185-7. PubMed ID: 8580492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
    Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
    Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged disease-free period in patients with advanced epithelial ovarian cancer after adoptive transfer of tumor-infiltrating lymphocytes.
    Fujita K; Ikarashi H; Takakuwa K; Kodama S; Tokunaga A; Takahashi T; Tanaka K
    Clin Cancer Res; 1995 May; 1(5):501-7. PubMed ID: 9816009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunotherapy for Stewart-Treves syndrome. Usefulness of intrapleural administration of tumor-infiltrating lymphocytes against massive pleural effusion caused by metastatic angiosarcoma.
    Furue M; Yamada N; Takahashi T; Kikuchi K; Tsuchida T; Ishibashi Y; Kobori O; Ihara A; Kitayama J; Minami M
    J Am Acad Dermatol; 1994 May; 30(5 Pt 2):899-903. PubMed ID: 8169271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of auto-tumor infiltrating lymphocytes induced by interleukin (IL)-12 with IL-2 on patients of primary hepatic carcinoma].
    Zhang YX; Wang XY; Liu JB; Zhang SQ; Chen YR
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):973-6. PubMed ID: 18756970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experimental and clinical studies on intrapleural instillations of interleukin-2 (IL-2) in patients with malignant pleural effusion].
    Suzuki H
    Nihon Geka Gakkai Zasshi; 1989 Nov; 90(11):1922-31. PubMed ID: 2608022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adoptive immunotherapy of advanced solid tumors: an eight year clinical experience.
    Semino C; Martini L; Queirolo P; Cangemi G; Costa R; Alloisio A; Ferlazzo G; Sertoli MR; Reali UM; Ratto GB; Melioli G
    Anticancer Res; 1999; 19(6C):5645-9. PubMed ID: 10697634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraperitoneal adoptive immunotherapy of ovarian carcinoma with tumor-infiltrating lymphocytes and low-dose recombinant interleukin-2: a pilot trial.
    Freedman RS; Edwards CL; Kavanagh JJ; Kudelka AP; Katz RL; Carrasco CH; Atkinson EN; Scott W; Tomasovic B; Templin S
    J Immunother Emphasis Tumor Immunol; 1994 Oct; 16(3):198-210. PubMed ID: 7834119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Better Clinical Efficiency of TILs for Malignant Pleural Effusion and Ascites than Cisplatin Through Intrapleural and Intraperitoneal Infusion.
    Chu H; Du F; Gong Z; Lian P; Wang Z; Li P; Hu B; Chi C; Chen J
    Anticancer Res; 2017 Aug; 37(8):4587-4591. PubMed ID: 28739756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Without prior stimulation, tumor-associated lymphocytes from malignant effusions lyse autologous tumor cells in the presence of bispecific antibody HEA125xOKT3.
    Strauss G; Gückel B; Wallwiener D; Moldenhauer G
    Clin Cancer Res; 1999 Jan; 5(1):171-80. PubMed ID: 9918216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Successful local adoptive immunotherapy for pleuritis carcinomatosa due to renal cell cancer. A case report].
    Saito T; Terunuma M; Koizumi T; Nishiyama T; Gou H; Tomita Y
    Nihon Hinyokika Gakkai Zasshi; 1992 Oct; 83(10):1717-20. PubMed ID: 1434278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A clinical study on adoptive immunotherapy of bone metastatic neoplasm with tumor infiltrating lymphocytes].
    Hua JM; Zheng ZG; Xu GD
    Zhonghua Zhong Liu Za Zhi; 1994 May; 16(3):203-6. PubMed ID: 7956700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The therapeutic efficacy of murine anti-tumor T cells: freshly isolated T cells are more therapeutic than T cells expanded in vitro.
    Evans R; Kamdar SJ; Duffy TM; Krupke DM; Fuller JA; Dudley ME
    Anticancer Res; 1995; 15(2):441-7. PubMed ID: 7763019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intratumoral adoptive immunotherapy with tumor infiltrating lymphocytes (TIL) in a melanoma patient leading to regression of local tumor mass. A case report.
    Möller P; Wittig B; Schadendorf D
    Anticancer Res; 1998; 18(2B):1237-41. PubMed ID: 9615794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes.
    Hwu P; Yang JC; Cowherd R; Treisman J; Shafer GE; Eshhar Z; Rosenberg SA
    Cancer Res; 1995 Aug; 55(15):3369-73. PubMed ID: 7614473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunomodulation in patients with epithelial ovarian cancer after adoptive transfer of tumor-infiltrating lymphocytes.
    Ikarashi H; Fujita K; Takakuwa K; Kodama S; Tokunaga A; Takahashi T; Tanaka K
    Cancer Res; 1994 Jan; 54(1):190-6. PubMed ID: 8261438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of 121 patients with malignant effusion due to advanced lung cancer by intrapleural transfer of autologous or allogeneic LAK cells combined with rIL-2.
    Liu X; Li D; Zhang C; Ba D; Liu J; Wan T; Li Z; Jin Y; He Y
    Chin Med Sci J; 1993 Sep; 8(3):186-9. PubMed ID: 8142637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological, histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients.
    Romano F; Cesana G; Berselli M; Gaia Piacentini M; Caprotti R; Bovo G; Uggeri F
    J Surg Oncol; 2004 Dec; 88(4):240-7. PubMed ID: 15565596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Study and clinical application of tumor-infiltrating lymphocytes isolated from hepatocarcinoma].
    Wang Y; Chen H; Wu M
    Zhonghua Wai Ke Za Zhi; 1995 Jan; 33(1):29-31. PubMed ID: 7774441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined immunotherapy with intracavital injection of activated lymphocytes, monocyte-derived dendritic cells and low-dose OK-432 in patients with malignant effusion.
    Morisaki T; Matsumoto K; Kuroki H; Kubo M; Baba E; Onishi H; Tasaki A; Nakamura M; Inaba S; Katano M
    Anticancer Res; 2003; 23(6a):4459-65. PubMed ID: 14666734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.